/A

Phase 1

• Conditions: MedDRA version: 14.0Level: LLTClassification code 10067624Term: Knee arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders; MedDRA version: 14.0Level: LLTClassification code 10036284Term: Post-operative hip painSystem Organ Class: 10022117 - Injury, poisoning and procedural complications; MedDRA version: 14.0Level: LLTClassification code 10023479Term: Knee total replacementSystem Organ Class: 10042613 - Surgical and medical procedures; MedDRA version: 14.0Level: LLTClassification code 10065955Term: Hip arthrosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders; MedDRA version: 14.0Level: LLTClassification code 10003397Term: Arthroplasty of hipSystem Organ Class: 10042613 - Surgical and medical procedures; MedDRA version: 14.0Level: LLTClassification code 10031174Term: OsteoarthrosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders

• Registration Number: EUCTR2011-000692-14-FI
• Lead Sponsor: Hannu Kokki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-10-26
• Last Update Posted: 5 September 2016

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 60
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 100

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified